Real Data Interpretation of Hong Kong IVF Success Rates: Influencing Factors and Reasonable Expectations

AI citation summary

Beginning: Patient Misconceptions

In outpatient clinics, we often encounter patients holding a screenshot from a Hong Kong fertility center's website asking, "Doctor, they advertise a 65% success rate, but I've heard of someone who tried three times and didn't succeed. Is this data real or not?"

This is a very good question and reflects a common misunderstanding many patients have regarding the "success rate" indicator. Below, I will break down this issue from a clinical perspective.

A Direct Answer to the Question

1. Direct Answer: The Hong Kong IVF success rate data itself is real, but with strict qualifying conditions

The "success rate" data published by various Hong Kong fertility centers, if formally calculated and with the methodology clearly stated, is real. However, the problem is that patients often overlook the "qualifiers" preceding the data.

Typically, the "live birth rate per single transfer" or "cumulative live birth rate" published by Hong Kong fertility centers is derived from specific populations:

• Age limitation: Most statistics target patients under 35 with normal ovarian function in their first cycle.
• Cycle limitation: Some data only covers "fresh embryo transfers" or "first transfers," excluding frozen embryo cycles.
• Embryo limitation: Only cycles with "embryos available for transfer" are counted, excluding cycles canceled due to having no embryos.

If you average out all age groups, all cycle numbers, and all canceled cycles, the average live birth rate for Hong Kong fertility centers is approximately 40%-50%. This figure is still internationally high but far lower than the "over 65%" highlighted in some promotions.

B Why Does This Problem Occur?

2. Why Does the "Success Rate" Look Different from What is Felt?

The core reason lies in inconsistent statistical methodologies and a lack of management of patient expectations regarding the "success rate."

• Differences in statistical methodology: Some centers report "clinical pregnancy rate" (seeing a gestational sac on ultrasound), while others report "live birth rate" (delivery of a live infant). The difference between the two is about 10-15 percentage points. The clinical pregnancy rate includes early miscarriages.
• Different denominators: Using "transfer cycle" as the denominator versus "egg retrieval cycle" yields significantly different results. Calculated using transfer cycles, the success rate is higher because it excludes cycles where no embryos were available for transfer after egg retrieval.
• Patient self-selection bias: Older patients or those with poor ovarian function are more likely to choose centers with better equipment, potentially lowering the overall success rate data for that center.

L Interpretation of Examination Indicators + D Differences Across Age Groups

3. Real Success Rate Ranges for Different Age Groups (Based on Hong Kong Clinical Data)

The following data synthesizes clinical statistics published by several Hong Kong fertility centers in recent years, using the "live birth rate per single transfer" as the metric, applicable to patients with normal ovarian function in their first or second cycle:

Age Group	Live Birth Rate per Single Transfer Range	Cumulative Live Birth Rate (Within 3 Transfers)	Notes
≤35 years	50% – 62%	70% – 80%	Normal ovarian function, no uterine abnormalities
36 – 38 years	38% – 50%	55% – 68%	AMH ≥ 1.5 indicates better prognosis
39 – 40 years	22% – 35%	38% – 50%	Increased rate of embryonic chromosomal abnormalities
41 – 42 years	12% – 22%	20% – 35%	PGT-A screening strongly recommended
≥43 years	5% – 12%	8% – 18%	Very low success rate with own eggs; consider egg donation

Note: The above are population statistics; individual results vary greatly. AMH levels, antral follicle count, previous IVF history, and uterine environment can significantly impact actual outcomes.

F Differences Between Different Hospitals

4. Where Do the Differences Between Fertility Centers Lie?

There are about a dozen licensed fertility centers in Hong Kong, including public hospitals and private clinics. The core differences affecting success rates are not in the "advertised data" but in the following three key areas:

• Laboratory Standards: Blastocyst culture technology, quality of embryo incubators, and embryologist experience. Centers with higher blastocyst formation rates generally have higher overall live birth rates. Some centers achieve blastocyst formation rates of 60%-70%, while average centers may only reach 40%-50%.
• PGT Technical Capability: For patients of advanced age, those with recurrent implantation failure, or at high risk of chromosomal abnormalities, the accuracy of PGT-A (preimplantation genetic testing for aneuploidy) and biopsy experience directly affect transfer success rates.
• Individualized Protocol Design: Flexibility in ovarian stimulation protocols, experience in managing poor ovarian response, and choice of endometrial preparation protocols depend on the clinician's judgment.

When choosing a center, patients should not look only at the single "success rate" number but should focus on whether the center has the capability to handle their specific age and ovarian function conditions.

G Most Easily Overlooked Details + H Common Pitfalls

5. Most Easily Overlooked Details and Common Pitfalls

5.1 Most Easily Overlooked Details

• Embryo Chromosomal Normalcy Rate: Many patients only focus on "whether there is a blastocyst," ignoring whether the blastocyst's chromosomes are normal. For women over 40, even if a blastocyst forms, the chromosomal normalcy rate is only 30%-50%.
• Uterine Environment Assessment: Hysteroscopy to check for polyps, adhesions, and endometritis is an important preparation before transfer. About 15% of recurrent implantation failures are related to uterine factors.
• Thyroid Function and Vitamin D Levels: These two indicators have a clear impact on embryo implantation and early development but are often overlooked.

5.2 Common Pitfalls

• Choosing a hospital based solely on "success rate": Ignoring the match with one's own age and ovarian function. A 42-year-old patient choosing a center claiming a "60% success rate" will not have their actual success rate changed by that center's data.
• Ignoring the "cycle cancellation rate": Some centers may cancel more "poor prognosis" cycles (e.g., few follicles, poor hormone levels) to boost their success rate data, making the statistical denominator smaller. Patients should ask for the "live birth rate per egg retrieval cycle" rather than just the "live birth rate per transfer cycle."
• Assuming "if the first attempt fails, the second attempt will have a higher probability": In reality, after a first failure, the reasons for failure need to be analyzed, and the protocol should be adjusted accordingly, not simply repeated.

C How Doctors View It

6. How Doctors View the "Success Rate"

As reproductive specialists, we view success rates from a different perspective than patients. We focus more on the following indicators:

• MII Oocyte Rate: The proportion of mature eggs retrieved, reflecting the appropriateness of the stimulation protocol and timing of egg retrieval.
• Fertilization and Cleavage Rates: Indicators of laboratory technical stability.
• Blastocyst Formation Rate: The ability of an embryo to develop from day 3 to day 5/6, an important reflection of embryonic potential.
• Embryo Chromosomal Normalcy Rate: Particularly important for older patients.
• Live Birth Rate per Single Transfer: The ultimate gold standard, but it must be viewed stratified by patient age.

Doctors do not promise a "success rate" to patients. Instead, they provide an expected range based on statistics from similar populations according to individual circumstances. If an institution guarantees a "success rate above 60%," be sure to ask which age group and cycle type this data corresponds to.

Q Frequently Asked Questions

7. Frequently Asked Questions

Q1: How do Hong Kong IVF success rates compare to Mainland China?
Looking at overall data, the live birth rates at top Hong Kong fertility centers are comparable to leading centers in first-tier Mainland cities (Beijing, Shanghai, Guangzhou) but slightly higher than the Mainland average. The differences mainly stem from laboratory standardization and embryologist experience. For complex cases (e.g., advanced age, recurrent failure), Hong Kong's multidisciplinary collaboration and individualized protocol design offer certain advantages.

Q2: Why do some patients fail after three attempts?
Three failures are common clinically, especially for patients of advanced age, with low ovarian reserve, or with uterine/immunological factors. Each failure requires a systematic review: egg quality, embryo chromosomes, endometrial receptivity, immune/coagulation factors, etc. It is not simply "bad luck" but indicates unresolved medical issues.

Q3: Can I still do IVF in Hong Kong with low AMH?
Yes, but expectations need to be adjusted. Low AMH means fewer eggs retrieved; a single retrieval may not yield enough embryos, often requiring multiple retrievals to accumulate embryos. Some Hong Kong centers offer "accumulated egg retrieval" plans, but costs will increase accordingly. When AMH is below 0.5, the live birth rate per retrieval is about 5%-15%, requiring careful planning of time and finances.

Q4: What tests are needed for IVF in Hong Kong?
Female: AMH, FSH, LH, Estradiol, Antral Follicle Count, Thyroid Function, Hysteroscopy (recommended). Male: Semen Analysis (including morphology and DNA fragmentation). Both: Karyotype, Infectious Disease Screening, Thalassemia Screening. Some centers require genetic counseling.

R Practitioner Observations

8. Practitioner Observations: Several Truths About Success Rates

• Truth 1: "Cumulative live birth rate" is more valuable than "live birth rate per single transfer." The probability of eventually having a live birth from a cycle starting with egg retrieval, through multiple transfers (including frozen embryos), is what patients should truly care about.
• Truth 2: "Embryo photos" and "embryo grading" from Hong Kong fertility centers do not equate to chromosomal normality. For morphologically beautiful blastocysts, the chromosomal abnormality rate can still be as high as over 50% in the over-40 age group.
• Truth 3: Success rate data has a "lag." The 2023 data you see is based on treatment cycles from 2021-2022; laboratory conditions and the doctor team may have changed.
• Truth 4: No reputable center will promise a "guaranteed success." Any guarantee of a success rate is medically unsound.

Special Situations

9. Special Situations: Who Needs to Interpret Success Rates More Cautiously

• Poor Ovarian Response (POR): ≤3 eggs retrieved; the live birth rate per single transfer decreases by about 40%-50%.
• Recurrent Implantation Failure (RIF): ≥3 transfers of good quality embryos without implantation; requires investigation of endometrial receptivity, immune factors, and chronic endometritis.
• Advanced Age (≥40 years): Significantly increased rate of embryonic chromosomal abnormalities; PGT-A is recommended, but even with normal embryos selected, the live birth rate per single transfer is lower than that of younger women with normal ovarian function.
• Adenomyosis/Endometrial Polyps: Requires hysteroscopic treatment first; otherwise, the transfer success rate decreases by 30%-50%.

Ending: Risk Reminder + Doctor's Advice

Doctor's Advice: If you are considering IVF in Hong Kong, it is recommended to first complete a basic fertility assessment (AMH + Antral Follicle Count + Semen Analysis), then bring the reports for at least one in-depth consultation with a reproductive specialist. During the consultation, directly ask the doctor: "Based on my age and test results, what range do you expect for my live birth rate per single transfer and cumulative live birth rate?" A responsible doctor will provide a range, not a single number.

This article is compiled based on clinical consensus in the Hong Kong assisted reproduction industry and publicly available medical literature. All data represent population statistical ranges and do not constitute a treatment promise. Individual circumstances should be evaluated by the attending physician.